In vitro experiments using EGR1 knockout or silence methods, along with EGR1 overexpression techniques, revealed that EGR1 had inhibitory impacts on the proliferation of HCC cells in vitro and the growth of xenografted tumors in vivo. Here, EGR1 is linked to hepatocellular carcinoma.